DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $26,000 | -16.1% | 6,400 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $31,000 | -20.5% | 6,400 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $39,000 | +5.4% | 6,400 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $37,000 | -82.4% | 6,400 | -50.0% | 0.00% | -50.0% |
Q4 2018 | $210,000 | +69.4% | 12,800 | +100.0% | 0.00% | -33.3% |
Q3 2018 | $124,000 | – | 6,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cortina Asset Management, LLC | 1,417,396 | $28,447,000 | 1.25% |
Investors Research Corp | 96,550 | $1,938,000 | 1.20% |
Phocas Financial Corp. | 663,187 | $13,310,000 | 1.12% |
BROADVIEW ADVISORS LLC | 338,000 | $6,784,000 | 0.96% |
Matarin Capital Management, LLC | 581,129 | $11,663,259,000 | 0.91% |
Sivik Global Healthcare LLC | 100,000 | $2,007,000 | 0.74% |
Iguana Healthcare Management, LLC | 50,000 | $1,004,000 | 0.65% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,824,190 | $76,751,000 | 0.56% |
Capital Impact Advisors, LLC | 63,403 | $1,272,000 | 0.55% |
Tekla Capital Management LLC | 640,492 | $12,855,000 | 0.50% |